Leukemia

4 currently open clinical trials

Treatment with ivosidenib or enasidenib for patients with mutations in enzymes (IDH1 or IDH2 mutation)
HOVON 150
Myelodysplastic syndromes: review of compliance with guidelines and their benefits for patients
SAKK 33/18
Optimizing chemotherapy for the treatment of leukemia
GRAALL 2014
Combination therapy in patients with chronic lymphocytic leukemia
SAKK 34/17
All cancer types